V. Leclerc

421 total citations
11 papers, 313 citations indexed

About

V. Leclerc is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, V. Leclerc has authored 11 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Infectious Diseases. Recurrent topics in V. Leclerc's work include Inhalation and Respiratory Drug Delivery (5 papers), Asthma and respiratory diseases (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). V. Leclerc is often cited by papers focused on Inhalation and Respiratory Drug Delivery (5 papers), Asthma and respiratory diseases (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). V. Leclerc collaborates with scholars based in France, United Kingdom and Canada. V. Leclerc's co-authors include Guillaume Birraux, W Wurst, Thomas D. Bethke, Wolfgang Timmer, Markus Neuhäuser, Armin Hatzelmann, John Kottakis, Vincent Gros, A. Cuvelier and I. Bourdeix and has published in prestigious journals such as Clinical Pharmacokinetics, British Journal of Clinical Pharmacology and Respiratory Medicine.

In The Last Decade

V. Leclerc

11 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Leclerc France 9 197 183 75 33 28 11 313
Jochen Sieber Germany 15 461 2.3× 67 0.4× 57 0.8× 23 0.7× 12 0.4× 39 951
Sladen Ge United Kingdom 8 68 0.3× 76 0.4× 52 0.7× 16 0.5× 21 0.8× 11 368
Atish Gheware India 9 86 0.4× 75 0.4× 113 1.5× 12 0.4× 43 1.5× 16 340
Daizo Ihaku Japan 10 201 1.0× 74 0.4× 63 0.8× 46 1.4× 38 1.4× 15 334
Golding Bird United Kingdom 8 175 0.9× 114 0.6× 42 0.6× 15 0.5× 40 1.4× 18 359
Nobue Ueki Japan 14 34 0.2× 184 1.0× 36 0.5× 53 1.6× 22 0.8× 48 531
Maria Carmina Pau Italy 12 133 0.7× 96 0.5× 74 1.0× 3 0.1× 37 1.3× 21 366
Carolyn Carter United States 5 75 0.4× 73 0.4× 17 0.2× 6 0.2× 54 1.9× 10 324
N. Barnes United Kingdom 8 425 2.2× 293 1.6× 40 0.5× 43 1.3× 6 0.2× 15 533
F. Rathgeb Germany 6 99 0.5× 351 1.9× 46 0.6× 8 0.2× 63 2.3× 9 421

Countries citing papers authored by V. Leclerc

Since Specialization
Citations

This map shows the geographic impact of V. Leclerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Leclerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Leclerc more than expected).

Fields of papers citing papers by V. Leclerc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Leclerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Leclerc. The network helps show where V. Leclerc may publish in the future.

Co-authorship network of co-authors of V. Leclerc

This figure shows the co-authorship network connecting the top 25 collaborators of V. Leclerc. A scholar is included among the top collaborators of V. Leclerc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Leclerc. V. Leclerc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Pasquier, Jérôme, Cécile Daccord, Simon R. Johnson, et al.. (2018). Air travel and incidence of pneumothorax in lymphangioleiomyomatosis. Orphanet Journal of Rare Diseases. 13(1). 222–222. 19 indexed citations
2.
3.
4.
Shi, Jun Yi, Guy Montay, Sunny Chapel, et al.. (2004). Pharmacokinetics and Safety of the Ketolide Telithromycin in Patients with Renal Impairment. The Journal of Clinical Pharmacology. 44(3). 234–244. 32 indexed citations
5.
Sobue, Satoshi, et al.. (2004). The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole. British Journal of Clinical Pharmacology. 57(6). 773–784. 13 indexed citations
6.
Kottakis, John, Giovanni Della Cioppa, Jacques P.H.M. Creemers, et al.. (2002). Faster Onset of Bronchodilation with Formoterol than with Salmeterol in Patients with Stable, Moderate‐Severe Copd: Results of a Randomized, Double‐Blind Clinical Study. Canadian Respiratory Journal. 9(2). 107–115. 42 indexed citations
7.
Timmer, Wolfgang, V. Leclerc, Guillaume Birraux, et al.. (2002). The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise‐Induced Asthma and Leads to Suppression of LPS‐Stimulated TNF‐α Ex Vivo. The Journal of Clinical Pharmacology. 42(3). 297–303. 99 indexed citations
8.
Benhamou, D., A. Cuvelier, Jean‐François Muir, et al.. (2001). Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil®AerolizerTM) with salbutamol (VentodiskTM). Respiratory Medicine. 95(10). 817–821. 56 indexed citations
9.
10.
Leclerc, V., et al.. (2000). Pharmacokinetics of Quinupristin/ Dalfopristin in Patients with Severe Chronic Renal Insufficiency. Clinical Pharmacokinetics. 39(1). 77–84. 7 indexed citations
11.
Dixon, Ruth, Stephanie French, John Kemp, et al.. (1998). Effect of Hepatic Impairment on the Pharmacokinetics of Zolmitriptan. The Journal of Clinical Pharmacology. 38(8). 694–701. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochen Sieber Breakdown of academic impact, for papers by Sladen Ge Breakdown of academic impact, for papers by Atish Gheware Breakdown of academic impact, for papers by Daizo Ihaku Breakdown of academic impact, for papers by Golding Bird Breakdown of academic impact, for papers by Nobue Ueki Breakdown of academic impact, for papers by Maria Carmina Pau Breakdown of academic impact, for papers by Carolyn Carter Breakdown of academic impact, for papers by N. Barnes Breakdown of academic impact, for papers by F. Rathgeb
Rankless by CCL
2026